409 related articles for article (PubMed ID: 20067706)
21. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
Scherließ R
Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
[TBL] [Abstract][Full Text] [Related]
22. Drug development of intranasally delivered peptides.
Campbell C; Morimoto BH; Nenciu D; Fox AW
Ther Deliv; 2012 Apr; 3(4):557-68. PubMed ID: 22834082
[TBL] [Abstract][Full Text] [Related]
23. Prodrugs in nasal drug delivery.
Tirucherai GS; Yang C; Mitra AK
Expert Opin Biol Ther; 2001 Jan; 1(1):49-66. PubMed ID: 11727547
[TBL] [Abstract][Full Text] [Related]
24. Dry powder nasal vaccines as an alternative to needle-based delivery.
Hickey AJ; Garmise RJ
Crit Rev Ther Drug Carrier Syst; 2009; 26(1):1-27. PubMed ID: 19496746
[TBL] [Abstract][Full Text] [Related]
25. Drug delivery systems from nose to brain.
Misra A; Kher G
Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
[TBL] [Abstract][Full Text] [Related]
26. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
Kashyap K; Shukla R
Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
[TBL] [Abstract][Full Text] [Related]
27. Anatomical and histological factors affecting intranasal drug and vaccine delivery.
Gizurarson S
Curr Drug Deliv; 2012 Nov; 9(6):566-82. PubMed ID: 22788696
[TBL] [Abstract][Full Text] [Related]
28. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
[TBL] [Abstract][Full Text] [Related]
29. In situ gel-forming system: an attractive alternative for nasal drug delivery.
Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
[TBL] [Abstract][Full Text] [Related]
30. The biopharmaceutical aspects of nasal mucoadhesive drug delivery.
Ugwoke MI; Verbeke N; Kinget R
J Pharm Pharmacol; 2001 Jan; 53(1):3-21. PubMed ID: 11206189
[TBL] [Abstract][Full Text] [Related]
31. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
32. Nasal route: an alternative approach for antiemetic drug delivery.
Ozsoy Y; Güngör S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1439-53. PubMed ID: 22004793
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
[TBL] [Abstract][Full Text] [Related]
34. Nasal route and drug delivery systems.
Türker S; Onur E; Ozer Y
Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
[TBL] [Abstract][Full Text] [Related]
35. An experimental study on nasal absorption of gentamycin in dogs.
Wang JQ; Bu GX
Chin Med J (Engl); 1994 Mar; 107(3):219-21. PubMed ID: 8088184
[TBL] [Abstract][Full Text] [Related]
36. Nasal delivery of high molecular weight drugs.
Ozsoy Y; Gungor S; Cevher E
Molecules; 2009 Sep; 14(9):3754-79. PubMed ID: 19783956
[TBL] [Abstract][Full Text] [Related]
37. Dehydration affects drug transport over nasal mucosa.
Ali A; Wahlgren M; Rembratt-Svensson B; Daftani A; Falkman P; Wollmer P; Engblom J
Drug Deliv; 2019 Dec; 26(1):831-840. PubMed ID: 31401887
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of sterylglucoside-modified liposomes for levonorgestrel delivery via nasal route.
Ding WX; Qi XR; Fu Q; Piao HS
Drug Deliv; 2007 Feb; 14(2):101-4. PubMed ID: 17364874
[TBL] [Abstract][Full Text] [Related]
39. [Development of Prediction System for Drug Absorption after Intranasal Administration Incorporating Physiologic Functions of Nose -Estimation of in Vivo Drug Permeation through Nasal Mucosa Using in Vitro Membrane Permeability].
Inoue D
Yakugaku Zasshi; 2021; 141(11):1235-1240. PubMed ID: 34719543
[TBL] [Abstract][Full Text] [Related]
40. An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.
Wong CYJ; Baldelli A; Tietz O; van der Hoven J; Suman J; Ong HX; Traini D
Int J Pharm; 2024 Apr; 654():123922. PubMed ID: 38401871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
